Web20 apr. 2024 · Prof. Dr. Ioanna Gouni-Berthold, Leiterin der Studienambulanz für Fettstoffwechselstörungen in der Poliklinik für Endokrinologie, Diabetologie und … Web12 apr. 2024 · Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area.
Did you know?
Web1 feb. 2002 · DOI: 10.1067/MHJ.2002.119997 Corpus ID: 837217; Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent. @article{GouniBerthold2002PolicosanolCP, title={Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent.}, author={Ioanna Gouni-Berthold … WebSehen Sie sich das Profil von Ioanna Gouni-Berthold im größten Business-Netzwerk der Welt an. Im Profil von Ioanna Gouni-Berthold ist 1 Job angegeben. Auf LinkedIn …
WebAdministration of APO (a)-LRx resulted in dose-dependent decreases in lipoprotein (a) levels, with mean percent decreases of 35% at a dose of 20 mg every 4 weeks, 56% at 40 mg every 4 weeks, 58% at 20 mg every 2 weeks, 72% at 60 mg every 4 weeks, and 80% at 20 mg every week, as compared with 6% with placebo (P values for the comparison with ... Web2 jun. 2024 · Prof. Dr. Ioanna Gouni-Berthold, Oberärztin in der Poliklinik für Endokrinologie, Diabetologie und Präventivmedizin der Uniklinik Köln, hat - wie bereits in …
WebProfessor Ioanna Gouni-Berthold is an Internist, Endocrinologist and head of the Lipid Research Clinic at at the Polyclinic for Endocrinology, Diabetes and Preventive Medicine … WebEfficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
WebTwo anti-proprotein convertase subtilisin/kexin type 9 (PCSK9) monoclonal antibodies, alirocumab and evolocumab, have been approved for the treatment of hypercholesterolaemia in certain patients. We reviewed data from Phase 3 …
WebManfredi Rizzo 1, Alessandro Colletti 2, Peter E Penson 3, Niki Katsiki 4, Dimitri P Mikhailidis 5, Peter P Toth 6, Ioanna Gouni-Berthold 7, John Mancini 8, David Marais 9, Patrick Moriarty 10, Massimiliano Ruscica 11, Amirhossein Sahebkar 12, Dragos Vinereanu 13, Arrigo Francesco Giuseppe Cicero 14, Maciej Banach 15; International Lipid Expert ... iphone tfgWeb16 jan. 2024 · Ioanna Gouni-Berthold, Jean-Claude Tardif, Seth Baum, Elizabeth Steinhagen-Thiessen, Michael Shapiro, Erik Stroes, Patrick Moriarty, Bǿrge … iphone tftpWeb17 mei 2006 · Gouni-Berthold I, Berthold HK. Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent. Am Heart J . 2002;143:356-36511835043 Google Scholar Crossref iphone tflopsWeb8 okt. 2012 · Drs. Heiner K. Berthold and Ioanna Gouni-Berthold are members of the ELAILa trial steering committee. The views expressed here are those of the authors and do not necessarily reflect the views of the other members. The authors have no conflict of interest associated with the subject matter. Addresss iphone texts went from blue to greenWebPharmaceuticals, an international, peer-reviewed Open Access journal. Journals. Active Journals Find a Journal Proceedings Series iphone tftWebPercutaneous Tricuspid Valve Repair: A Promising Treatment for Heart Transplant Patients With Severe Tricuspid Regurgitation. iphone tfwWeb28 mrt. 2008 · Ioanna Gouni-Berthold, MD, 1 Heiner K. Berthold, MD, PHD, 2 Christos S. Mantzoros, MD, 3 Michael Böhm, MD, 4 and Wilhelm Krone, MD 1 Author information Article notes Copyright and License information This article has been cited by other articles in PMC. Associated Data Supplementary Materials Abstract 1 2 2 3 5 6 ). iphone texts with effects